Mergers and Acquisitions

GettyImages: Devonyu

Lundbeck to buy Prexton in potential $1bn+ deal

By Staff Reporter

The Danish drugmaker says it will take responsibility for commercial manufacturing after acquiring Parkinson’s disease candidate foliglurax in a deal worth up to €905m ($1.1bn).